Maruti Suzuki Suffers COVID-19 Impact, Sales Down by 47 Percent in March

Image for representational objective (Photo: Reuters)

The auto big stated that it offered 83,792 items final month as automakers within the nation had been pressured to droop operations amid a 21-day nationwide lockdown.

  • PTI New Delhi
  • Last Updated: April 1, 2020, 1:30 PM IST

Maruti Suzuki India stated on Wednesday it offered 83,792 items in March as automakers within the nation had been pressured to droop operations amid a nationwide lockdown aimed to include the unfold of the coronavirus pandemic.

The carmaker offered 158,076 items final 12 months however stated the numbers weren’t comparable as the corporate needed to droop operations from March 22, in step with the federal government’s order.

Related Post

Last week, the federal government despatched India right into a 21-day lockdown to curb the unfold of the virus, forcing automakers corresponding to Maruti, Mahindra & Mahindra, Hyundai, Ford and Toyota to droop automotive manufacturing.

India’s auto trade, which is already beneath strain from a slowing financial system and lean demand, has been additional hit by the suspension of operations.

Ahead of this, the auto big had introduced that it’ll start the manufacturing of ventilators at its plant to assist with the rising instances of COVID-19 in India. An association was made with AgVa Healthcare, an current authorized producer of ventilators. MSIL would work with AgVa Healthcare to quickly scale up manufacturing of ventilators. The intention is to achieve a quantity of 10,000 items per thirty days.

AgVa Healthcare can be accountable for the know-how, efficiency and associated issues for all of the ventilators produced and offered by them.

MSIL would use its suppliers to supply the required quantity of parts and use its expertise and information to improve methods for the manufacturing and high quality management of the upper volumes. Any different help required would even be supplied. MSIL would additionally assist, to the required extent to rearrange to finance and procure all permissions and approvals required to allow the upper manufacturing. MSIL would offer these companies freed from price to AgVa Healthcare.

Source link

This post was last modified on April 2, 2020 10:05 am

Joy: Hi Folks. I am Jyoti, pursuing my passion to write content on Technology and Automobiles. I am a B.Tech (IT) graduate who loves to write content on different niche. Being passionate since college days, I took it as my full-time career. I started this blog to deliver unbiased reviews to the readers and let them choose the right product based on their reviews. If you want to contact me, you can drop your mail at

This website uses cookies.